Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study

Urology

Volumn 52, Issue 2, 1998, Pages 237-246

  Rietbergen, John B W ^a   Kranse, Ries ^b   Hoedemaeker, Robert F ^b   Kruger, Arto E Boeken ^b   Bangma, Chris H ^b   Kirkels, Wim J ^b   Schröder, Fritz H ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; TRANSRECTAL ULTRASONOGRAPHY;

AGED; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE;

EID: 0032146040     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00138-1     Document Type: Article

References (29)

1. Catalona W.J., Hudson M.A., Scardino P.T., et al. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer receiver operating characteristic curves . J Urol. 152:1994;2037-2042.
2. Labrie F., Dupont A., Suburu R., et al. Optimized strategy for detection of early stage, curable prostate cancer role of prescreening with prostate-specific antigen . Clin Invest Med. 16:1993;425-439.
3. Mettlin C., Murphy G.P., Babaian R.J., et al. The results of a five-year early prostate cancer detection intervention Investigators of the American Cancer Society National Prostate Cancer Detection Project . Cancer. 77:1996;150-159.
4. Crawford E.D., DeAntoni E.P., Etzioni R., et al. Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program The Prostate Cancer Education Council . Urology. 47:1996;863-869.
5. Stamey T.A., Yang N., Hay A.R., et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 317:1987;909-916.
6. Robles J.M., Morell A., Redorta J.P., et al. Clinical behaviour of prostate specific antigen and prostatic acid phosphatase a comparative study . Eur Urol. 14:1988;360-366.
7. Glenski W.J., Malek R.S., Myrtle J.F., et al. Sustained substantially increased concentration of prostate specific antigen in the absence of prostatic malignant disease an unusual clinical scenario . Mayo Clin Proc. 67:1992;249-252.
8. Babaian R.J., Fritsche H.A., Evans R.B. Prostate-specific antigen and prostate gland volume correlation and clinical application . J Clin Lab Anal. 4:1990;135-137.
9. Babaian R.J., Miyashita H., Evans R.B., et al. The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer relationship to gland volume and age . J Urol. 147:1992;837-840.
10. Benson M.C., Whang I.S., Olsson C.A., et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol. 147:1992;817-821.
11. Bazinet M., Meshref A.W., Trudel C., et al. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology. 43:1994;44-51.
12. Rommel F.M., Agusta V.E., Breslin J.A., et al. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol. 151:1994;88-93.
13. Littrup P.J., Kane R.A., Mettlin C.J., et al. Cost-effective prostate cancer detection Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project . Cancer. 74:1994;3146-3158.
14. Brawer M.K., Aramburu E.A., Chen G.L., et al. The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol. 150:1993;369-373.
15. Cookson M.S., Floyd M.K., Ball T.P. Jr, et al. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J Urol. 154:1995;1070-1073.
16. Catalona W.J., Richie J.P., deKernion J.B., et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer receiver operating characteristic curves . J Urol. 152:1994;2031-2036.
17. Bare R., Hart L., McCullough D.L. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy. Urology. 43:1994;191-196.
18. Lepor H., Wang B., Shapiro E. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology. 44:1994;199-205.
19. Kalish J., Cooner W.H., Graham S.D. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology. 43:1994;601-606.
20. Zlotta A.R., Djavan B., Marberger M., et al. Prostate specific antigen density of the transition zone a new effective parameter for prostate cancer prediction . J Urol. 157:1997;1315-1321.
21. Gohji H., Nomi M., Egawa S., et al. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Cancer. 79:1997;1969-1976.
22. Bangma C.H., Kranse R., Blijenberg B.G., et al. The value of screening tests in the detection of prostate cancer Part I: Results of a retrospective evaluation of 1726 men . Urology. 46:1995;773-778.
23. Lee F., Gray J.M., McLeary R.D., et al. Transrectal ultrasound in the diagnosis of prostate cancer location, echogenicity, histopathology, and staging . Prostate. 7:1985;117-129.
24. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:1986;307-310.
25. Hollis S. Analysis of method comparison studies. Ann Clin Biochem. 33:1996;1-4.
26. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 148:1982;839-843.
27. Bangma C.H., Niemer A.Q., Grobbee D.E., et al. Transrectal ultrasonic volumetry of the prostate in vivo comparison of different methods . Prostate. 28:1996;107-110.
28. Littrup P.J., Wiliams C.R., Egglin T.K., et al. Determination of prostate volume with transrectal US for cancer screening Part II. Accuracy of in vitro and in vivo techniques . Radiology. 179:1991;49-53.
29. Kurita Y., Ushiyama T., Suzuki K., et al. PSA value adjusted for the transition zone volume in the diagnosis of prostate cancer. Int J Urol. 3:1996;367-372.